Your browser doesn't support javascript.
loading
Albumin-to-Fibrinogen Ratio as an Independent Prognostic Parameter in Untreated Chronic Lymphocytic Leukemia: A Retrospective Study of 191 Cases.
Zou, Yi-Xin; Qiao, Jia; Zhu, Hua-Yuan; Lu, Rui-Nan; Xia, Yi; Cao, Lei; Wu, Wei; Jin, Hui; Liu, Wen-Jie; Liang, Jin-Hua; Wu, Jia-Zhu; Wang, Li; Fan, Lei; Xu, Wei; Li, Jian-Yong.
Afiliação
  • Zou YX; Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, China.
  • Qiao J; Key Laboratory of Hematology of Nanjing Medical University, Nanjing, China.
  • Zhu HY; Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing, China.
  • Lu RN; Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, China.
  • Xia Y; Key Laboratory of Hematology of Nanjing Medical University, Nanjing, China.
  • Cao L; Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing, China.
  • Wu W; Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, China.
  • Jin H; Key Laboratory of Hematology of Nanjing Medical University, Nanjing, China.
  • Liu WJ; Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing, China.
  • Liang JH; Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, China.
  • Wu JZ; Key Laboratory of Hematology of Nanjing Medical University, Nanjing, China.
  • Wang L; Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing, China.
  • Fan L; Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, China.
  • Xu W; Key Laboratory of Hematology of Nanjing Medical University, Nanjing, China.
  • Li JY; Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing, China.
Cancer Res Treat ; 51(2): 664-671, 2019 Apr.
Article em En | MEDLINE | ID: mdl-30064197
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fibrinogênio / Leucemia Linfocítica Crônica de Células B / Albumina Sérica Humana Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Res Treat Ano de publicação: 2019 Tipo de documento: Article País de afiliação: China País de publicação:
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fibrinogênio / Leucemia Linfocítica Crônica de Células B / Albumina Sérica Humana Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Res Treat Ano de publicação: 2019 Tipo de documento: Article País de afiliação: China País de publicação: